NOT KNOWN FACTUAL STATEMENTS ABOUT (+)-JQ-1 RESEARCH STUDIES

For drug discovery geared toward building 2nd- or third-generation therapeutics, 1 could reasonably argue that TID/MoA needs to be acquired early in the procedure so as to add value, as current remedies are offered to Those people in need (Determine 1). For Other people, Primarily the neurological and psychiatric diseases for which TID/MoA is a gre